LDA analysis for Study ST003433

(Analysis AN005639 )

Select 3 or more experimental factors for PCA analysis.
GroupExperimental factor
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM Fasnall + 1 uM GSK2194069
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM Fasnall + 5 mM DMM
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:40 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:40 uM Fasnall + 1 uM GSK2194069
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:40 uM Fasnall + 5 mM DMM
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM DMM
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 uM Fasnall + 1 uM GSK2194069
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 uM Fasnall + 5 mM DMM
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:Control
Sample source:NA | Sample Type:Blank | Drug Treatment:NA
Sample source:NA | Sample Type:Medium | Drug Treatment:NA
Sample source:NA | Sample Type:QC | Drug Treatment:NA

OR

Perform LDA on individual factors (all analyses in study)
  logo